Andra Ap Fonden Catalent, Inc. Transaction History

Andra Ap Fonden

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $5.56 Million - $6.04 Million	99,000 New	99,000 $6 Million
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $234,080 - $329,010	5,500 New	5,500 $310,000
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $273,174 - $534,600	6,600 New	6,600 $297,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $1.14 Million - $1.49 Million	-13,100 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$119.57 - $139.07 $1.49 Million - $1.74 Million	-12,500 Reduced 48.83%	13,100 $1.68 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $2.79 Million - $3.64 Million	25,600 New	25,600 $3.41 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $1.35 Million - $1.56 Million	-13,500 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $933,892 - $1.15 Million	-9,200 Reduced 40.53%	13,500 $1.42 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $1.74 Million - $2.14 Million	20,300 Added 845.83%	22,700 $2.36 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $174,576 - $222,000	2,400 New	2,400 $206,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.